Medinice SA

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: PLMDNCE00016
PLN
13.98
0.8 (6.07%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
0.19
0.23
0.25
0.28
0.37
0.16
0.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
0.19
0.23
0.25
0.28
0.37
0.16
0.00
Raw Material Cost
4.41
5.14
4.51
3.54
2.69
1.67
1.30
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
1.96
2.67
2.92
1.81
0.75
0.26
0.25
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.05
0.06
0.06
0.06
0.05
0.01
0.01
Selling and Distribution Expenses
0.36
0.67
0.26
0.10
0.04
0.41
0.05
Other Expenses
-0.19
-0.27
-0.29
-0.18
-0.07
-0.03
-0.03
Total Expenditure (Excl Depreciation)
4.84
5.88
4.85
3.72
2.80
2.09
1.35
Operating Profit (PBDIT) excl Other Income
-4.699999999999999
-5.699999999999999
-4.6000000000000005
-3.4000000000000004
-2.4
-1.9
-1.4000000000000001
Other Income
0.34
0.88
0.05
1.12
-0.16
-0.04
-0.32
Operating Profit (PBDIT)
-4.09
-4.52
-4.35
-2.10
-2.33
-1.88
-1.72
Interest
0.05
0.06
0.06
0.06
0.05
0.01
0.01
Exceptional Items
41.92
-0.20
-0.28
-0.43
-0.35
0.00
0.00
Gross Profit (PBDT)
-4.22
-4.91
-4.26
-3.25
-2.32
-1.51
-1.30
Depreciation
0.23
0.28
0.23
0.28
0.29
0.12
0.00
Profit Before Tax
37.55
-5.07
-4.92
-2.88
-3.02
-2.02
-1.73
Tax
-0.03
0.00
0.00
0.01
0.00
0.23
-0.08
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
37.58
-5.07
-4.92
-2.88
-3.02
-2.25
-1.65
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
37.58
-5.07
-4.92
-2.88
-3.02
-2.25
-1.65
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
-0.00
-0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
37.58
-5.07
-4.92
-2.89
-3.02
-2.25
-1.65
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.1
0.1
0.1
0.1
0.1
0.1
0.1
Reserves
81.01
33.17
37.13
40.51
16.98
8.23
2.92
Earnings per share (EPS)
5.62
-0.79
-0.79
-0.5
-0.56
-0.52
-0.5
Diluted Earnings per share
5.62
-0.79
-0.79
-0.5
-0.56
-0.52
-0.5
Operating Profit Margin (Excl OI)
-2479.26%
-2528.0%
-1884.96%
-1228.07%
-661.83%
-1198.52%
-126217.29%
Gross Profit Margin
20096.81%
-2128.44%
-1908.94%
-910.18%
-733.6%
-1152.3%
-155727.4%
PAT Margin
19987.77%
-2254.22%
-2002.03%
-1011.58%
-812.1%
-1366.43%
-148881.79%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2024 is 0.00% vs 0.00% in Dec 2023

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2024 is 837.25% vs -4.08% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2024 is 18.52% vs -22.73% in Dec 2023

stock-summary

Interest

YoY Growth in year ended Dec 2024 is 0.00% vs 0.00% in Dec 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2024 has improved from Dec 2023

Compare Annual Results Of Medinice SA With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(PLN)
Change(%)
Net Sales
0.19
52.85
-52.66
-99.64%
Other Operating Income
0.00
0.00
0.00
Total Operating income
0.19
52.85
-52.66
-99.64%
Raw Material Cost
4.41
50.61
-46.20
-91.29%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
1.96
14.62
-12.66
-86.59%
Power Cost
0
0
0.00
Manufacturing Expenses
0.05
0.98
-0.93
-94.90%
Selling and Distribution Expenses
0.36
1.81
-1.45
-80.11%
Other Expenses
-0.19
-1.56
1.37
87.82%
Total Expenditure (Excl Depreciation)
4.84
52.42
-47.58
-90.77%
Operating Profit (PBDIT) excl Other Income
-4.66
0.43
-5.09
-1,183.72%
Other Income
0.34
0.85
-0.51
-60.00%
Operating Profit (PBDIT)
-4.09
4.65
-8.74
-187.96%
Interest
0.05
0.98
-0.93
-94.90%
Exceptional Items
41.92
0.00
41.92
Gross Profit (PBDT)
-4.22
2.24
-6.46
-288.39%
Depreciation
0.23
3.36
-3.13
-93.15%
Profit Before Tax
37.55
0.31
37.24
12,012.90%
Tax
-0.03
-0.23
0.20
86.96%
Provisions and contingencies
0
0
0.00
Profit After Tax
37.58
0.54
37.04
6,859.26%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
37.58
0.54
37.04
6,859.26%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
37.58
0.54
37.04
6,859.26%
Equity Capital
0
0
0.00
Face Value
0.10
1.00
0.00
Reserves
81.01
47.33
33.68
71.16%
Earnings per share (EPS)
5.62
0.13
5.49
4,223.08%
Diluted Earnings per share
5.62
0.13
5.49
4,223.08%
Operating Profit Margin (Excl OI)
-2,479.26%
0.81%
0.00
-2,480.07%
Gross Profit Margin
20,096.81%
6.94%
0.00
20,089.87%
PAT Margin
19,987.77%
1.01%
0.00
19,986.76%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 0.02 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 0.00% vs 0.00% in Dec 2023

Annual - Consolidate Net Profit
Consolidate Net Profit 3.76 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 837.25% vs -4.08% in Dec 2023

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) -0.44 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 18.52% vs -22.73% in Dec 2023

Annual - Interest
Interest 0.01 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 0.00% vs 0.00% in Dec 2023

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) -2,479.26%
in Dec 2024

Figures in %
stock-summary

YoY Growth in year ended Dec 2024 has improved from Dec 2023